Quantbot Technologies LP Takes $1.27 Million Position in CME Group Inc. $CME

Quantbot Technologies LP acquired a new stake in shares of CME Group Inc. (NASDAQ:CME) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 5,752 shares of the financial services provider’s stock, valued at approximately $1,270,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Whipplewood Advisors LLC grew its holdings in shares of CME Group by 2,075.0% during the first quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 83 shares during the last quarter. Elkhorn Partners Limited Partnership acquired a new stake in shares of CME Group during the 4th quarter worth approximately $27,000. Hilton Head Capital Partners LLC bought a new stake in shares of CME Group in the 4th quarter worth approximately $28,000. Mowery & Schoenfeld Wealth Management LLC acquired a new position in CME Group during the 2nd quarter valued at approximately $28,000. Finally, Legacy Wealth Managment LLC ID boosted its position in CME Group by 191.9% during the 4th quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock valued at $29,000 after purchasing an additional 71 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.

Wall Street Analyst Weigh In

CME has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft downgraded CME Group from a “buy” rating to a “hold” rating and lowered their price objective for the stock from $286.00 to $270.00 in a research note on Wednesday, August 19th. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Weiss Ratings lowered shares of CME Group from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, August 11th. Keefe, Bruyette & Woods raised shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price objective on the stock in a report on Thursday, June 18th. Finally, Wall Street Zen cut shares of CME Group from a “sell” rating to a “strong sell” rating in a report on Saturday, August 1st. Nine research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, CME Group currently has an average rating of “Hold” and an average price target of $288.56.

Insiders Place Their Bets

In related news, Director William R. Shepard bought 325 shares of the firm’s stock in a transaction that occurred on Thursday, June 25th. The stock was purchased at an average price of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares of the company’s stock, valued at approximately $60,050,111.94. This represents a 0.12% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. 0.30% of the stock is owned by insiders.

CME Group Stock Down 0.7%

Shares of CME Group stock opened at $277.32 on Wednesday. The business’s fifty day moving average price is $251.75 and its two-hundred day moving average price is $279.35. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. The company has a market capitalization of $99.72 billion, a P/E ratio of 23.52, a PEG ratio of 3.32 and a beta of 0.23. CME Group Inc. has a 1-year low of $218.31 and a 1-year high of $329.16.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion during the quarter, compared to analyst estimates of $1.68 billion. During the same quarter in the previous year, the firm posted $2.96 EPS. The firm’s quarterly revenue was up .8% on a year-over-year basis. As a group, research analysts forecast that CME Group Inc. will post 12.27 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a $1.30 dividend. The ex-dividend date of this dividend is Wednesday, September 9th. This represents a $5.20 annualized dividend and a yield of 1.9%. CME Group’s dividend payout ratio is presently 44.11%.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.